C&C International Co Ltd

C&C International maintains a strong liquidity position, with a current ratio of 3.21 and cash and equivalents amounting to KRW 164.64 billion, which represents 37.6% of total assets. The company's debt-to-equity ratio is 0.15, indicating a conservative capital structure with limited leverage. Despite a negative free cash flow of KRW -4.81 billion, the company's operating cash flow of KRW 26.73 billion supports its liquidity position. The company's profitability metrics show a return on equity (ROE) of 4.03% and a return on assets (ROA) of 3.26%, which are below the industry median for personal care products. This suggests that C&C International is underperforming in terms of capital efficiency and asset utilization compared to its peers. C&C International's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided. This lack of diversification may expose the company to higher operational and market risks if demand for personal care products in its primary market fluctuates. The company's growth trajectory is not clearly defined in the available data, as no specific revenue growth rates or future projections are provided. However, the negative free cash flow and capital expenditures of KRW -18.68 billion suggest that the company is investing in its operations, which could support future growth. C&C International faces low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low dilution potential is supported by the absence of recent share issuance or ATM/shelf disclosures. However, the negative free cash flow may necessitate future financing, which could introduce dilution pressure. Recent events, including analyst estimates and price targets, indicate a cautious outlook. The mean price target of KRW 37,500 and a mean recommendation of 2.33 suggest a "hold" rating, with no strong buy recommendations. This reflects a neutral sentiment among analysts regarding the company's near-term prospects.